These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 22126568)
21. Effectiveness of adjuvant tamoxifen therapy among older women with early stage breast cancer. Owusu C; Lash TL; Silliman RA Breast J; 2007; 13(4):374-82. PubMed ID: 17593042 [TBL] [Abstract][Full Text] [Related]
22. Survival of women with breast cancer in Kaunas Region, Lithuania. Ivanauskienė R; Gedminaitė J; Juozaitytė E; Vanagas G; Simoliūnienė R; Padaiga Z Medicina (Kaunas); 2012; 48(5):272-6. PubMed ID: 22864275 [TBL] [Abstract][Full Text] [Related]
23. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival. Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247 [TBL] [Abstract][Full Text] [Related]
24. Important prognostic factors for survival in patients with malignant pleural effusion. Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349 [TBL] [Abstract][Full Text] [Related]
25. Survival analysis of Malaysian women with breast cancer: results from the University of Malaya Medical Centre. Mohd Taib NA; Yip CH; Mohamed I Asian Pac J Cancer Prev; 2008; 9(2):197-202. PubMed ID: 18712958 [TBL] [Abstract][Full Text] [Related]
26. Men with breast cancer have same disease-specific and event-free survival as women. Marchal F; Salou M; Marchal C; Lesur A; Desandes E Ann Surg Oncol; 2009 Apr; 16(4):972-8. PubMed ID: 19184227 [TBL] [Abstract][Full Text] [Related]
27. Five year survival of women with breast cancer in Yazd. Fallahzadeh H; Momayyezi M; Akhundzardeini R; Zarezardeini S Asian Pac J Cancer Prev; 2014; 15(16):6597-601. PubMed ID: 25169494 [TBL] [Abstract][Full Text] [Related]
28. Burden of breast cancer in Iran: a study of the Tehran population based cancer registry. Mousavi SM; Mohaghegghi MA; Mousavi-Jerrahi A; Nahvijou A; Seddighi Z Asian Pac J Cancer Prev; 2006; 7(4):571-4. PubMed ID: 17250429 [TBL] [Abstract][Full Text] [Related]
29. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy. Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572 [TBL] [Abstract][Full Text] [Related]
30. Modeling of breast cancer prognostic factors using a parametric log-logistic model in Fars province, Southern Iran. Zare N; Doostfatemeh M; Rezaianzadeh A Asian Pac J Cancer Prev; 2012; 13(4):1533-7. PubMed ID: 22799361 [TBL] [Abstract][Full Text] [Related]
31. The impact of renin-angiotensin system, angiotensin І converting enzyme (insertion/deletion), and angiotensin ІІ type 1 receptor (A1166C) polymorphisms on breast cancer survival in Iran. Namazi S; Daneshian A; Mohammadianpanah M; Jafari P; Ardeshir-Rouhani-Fard S; Nasirabadi S Gene; 2013 Dec; 532(1):125-31. PubMed ID: 24055489 [TBL] [Abstract][Full Text] [Related]
32. [Clinical characteristics and survival analysis of 22 cases of pure epithelial breast metaplastic carcinoma]. Meng HM; Yang YF; Qi LQ; Gu L Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):525-9. PubMed ID: 24257306 [TBL] [Abstract][Full Text] [Related]
33. Treatment for breast sarcoma: a large, single-centre series. Pencavel T; Allan CP; Thomas JM; Hayes AJ Eur J Surg Oncol; 2011 Aug; 37(8):703-8. PubMed ID: 21628089 [TBL] [Abstract][Full Text] [Related]
34. Application of Cox and Parametric Survival Models to Assess Social Determinants of Health Affecting Three-Year Survival of Breast Cancer Patients. Mohseny M; Amanpour F; Mosavi-Jarrahi A; Jafari H; Moradi-Joo M; Davoudi Monfared E Asian Pac J Cancer Prev; 2016; 17(S3):311-6. PubMed ID: 27165244 [TBL] [Abstract][Full Text] [Related]
35. Survival analysis of breast cancer patients using Cox and frailty models. Faradmal J; Talebi A; Rezaianzadeh A; Mahjub H J Res Health Sci; 2012 Dec; 12(2):127-30. PubMed ID: 23241526 [TBL] [Abstract][Full Text] [Related]
36. Localized therapy for male breast cancer: functional advantages with comparable outcomes using breast conservation. Fogh S; Kachnic LA; Goldberg SI; Taghian AG; Powell SN; Hirsch AE Clin Breast Cancer; 2013 Oct; 13(5):344-9. PubMed ID: 23891587 [TBL] [Abstract][Full Text] [Related]
37. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. Coleman R; Cameron D; Dodwell D; Bell R; Wilson C; Rathbone E; Keane M; Gil M; Burkinshaw R; Grieve R; Barrett-Lee P; Ritchie D; Liversedge V; Hinsley S; Marshall H; Lancet Oncol; 2014 Aug; 15(9):997-1006. PubMed ID: 25035292 [TBL] [Abstract][Full Text] [Related]
38. Treatment options for locally advanced breast cancer--experience in an Asian tertiary hospital. Chong HY; Taib NA; Rampal S; Saad M; Bustam AZ; Yip CH Asian Pac J Cancer Prev; 2010; 11(4):913-7. PubMed ID: 21133600 [TBL] [Abstract][Full Text] [Related]
39. What is the essential element(s) to avoid axillary involvement in breast cancer patients? Akbari ME; Hassani M; Akbari A; Nafisi N; Naserinia SS; Jafari R; Razaghi Z Breast J; 2013; 19(1):121-3. PubMed ID: 23279445 [No Abstract] [Full Text] [Related]
40. Survival of thyroid cancer and social determinants in Iran, 2001-2005. Khayamzadeh M; Khayamzadeh M; Tadayon N; Salmanian R; Zham H; Razzaghi Z; Akbari ME Asian Pac J Cancer Prev; 2011; 12(1):95-8. PubMed ID: 21517238 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]